US WorldMeds
Develops, manufactures, and markets proprietary specialty pharmaceuticals, which are sold both in the United States and internationally. Products include Revonto for treating malignant hyperthermia; MyoBloc, NerBloc, and NeuroBloc for cervical dystonia, a neurological movement disorder, in adults; and Apokyn for acutely treating hypomobility associated with Parkinsons disease.
2012 STATISTICS
3-year growth:441%
2011 Revenue:$36.7 million
2008 Revenue:$6.8 million
Employees:64
Jobs added, prev. 3 years:49
2012 HONORS
#52
Top 100 Health Companies
#4
Top 100 Kentucky Companies
